Miaomiao Ge is the Executive Director and Head of Experimental Medicine Oncology Biostatistics at Boehringer Ingelheim. With a Ph. D. from the University of Connecticut, she leads teams focused on early-stage clinical development and statistical innovation for new cancer treatments, having progressed through several leadership roles within the company.
She has co-authored multiple publications on innovative statistical methods for clinical trials, including Bayesian trial designs and sample size re-estimation techniques.
Read the full overview →Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.